Over the latest trailing 12-month period, total return cagr is -94.75%. The comparable SPY value is +16.94%. Year-to-date total return is -95.71%. Total return includes price appreciation and reinvested dividends.
Over longer horizons, Total Return CAGR averages -41.81% over 3 years and -59.51% over 5 years; the trailing 12 months came in at -94.75%. Total return includes dividends reinvested. The total return CAGR includes both price appreciation and dividends reinvested. This gives a more complete picture of the company's investment performance.
Gossamer Bio, Inc. (GOSS)
Total Return growth vs the same calendar quarter one year earlier, last 28 comparable quarters.
Quarter-end value of $100 invested at the start of the available history, with dividends reinvested; the newest quarter may be quarter-to-date. Q4 2026 (2026-10-05): $0.74.
| Year | Total return for the year |
|---|---|
| 2026 (YTD) | -95.71% |
| 2025 | +242.68% |
| 2024 | -0.86% |
| 2023 | -57.95% |
| 2022 | -80.81% |
| 2021 | +16.96% |
| 2020 | -38.13% |
| Period | Period End | QoQ Return | YoY Return |
|---|---|---|---|
| Q4 2026 (QTD) | 2026-10-05 | N/A | -95.7% |
| Q3 2026 | 2026-09-30 | N/A | -94.7% |
| Q2 2026 | 2026-06-30 | -49.9% | -86.8% |
| Q1 2026 | 2026-03-31 | -89.5% | -71.9% |
| Q4 2025 | 2025-12-30 | +10.6% | +255.3% |
| Q3 2025 | 2025-09-29 | +125.6% | +193.7% |
| Q2 2025 | 2025-06-27 | +6.8% | +31.3% |
| Q1 2025 | 2025-03-28 | +33.2% | -0.8% |
| Q4 2024 | 2024-12-30 | -8.5% | -0.5% |
| Q3 2024 | 2024-09-27 | +0.8% | +15.3% |
| Q2 2024 | 2024-06-27 | -19.3% | -21.3% |
| Q1 2024 | 2024-03-28 | +33.7% | -3.3% |
| Q4 2023 | 2023-12-28 | +6.0% | -60.4% |
| Q3 2023 | 2023-09-29 | -31.2% | -93.0% |
| Q2 2023 | 2023-06-29 | -0.8% | -85.5% |
| Q1 2023 | 2023-03-30 | -45.3% | -85.9% |
Calendar returns: QoQ compares the prior calendar quarter; YoY compares the same calendar quarter a year earlier. The newest quarter is in progress (quarter-to-date).
